Anti-pan Synuclein antibody, prediluted (ab15535)


  • Product nameAnti-pan Synuclein antibody, prediluted
    See all pan Synuclein primary antibodies
  • Description
    Rabbit polyclonal to pan Synuclein, prediluted
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Rat
  • Immunogen

    Synthetic peptide within Human pan Synuclein (N terminal). The exact sequence is proprietary. A synthetic peptide corresponding to near N-terminal of human alpha, beta, gamma Synuclein protein.

  • Positive control
    • IHC-P: Human brain tissue.



Our Abpromise guarantee covers the use of ab15535 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Ready-to-use for 10 min at RT. Boil tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at RT for 20 min.


  • RelevanceSynucleins are small, soluble proteins expressed primarily in neural tissue and in certain tumors. The family includes three known proteins: alpha, beta and gamma synucleins. Synuclein-alpha is primarily localized at the presynaptic region of axons and it may be involved in the regulation of dopamine release and transport. However, it can form filamentous aggregates that are the major non amyloid component of intracellular inclusions in several neurodegenerative diseases (synucleinopathies). Synuclein-alpha may induce fibrillization of the microtubule-associated protein tau and it reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase 3 activation. Synuclein-alpha is involved in Parkinson's disease, Lewy body dementia, Brain iron accumulation type 1 (NBIA1, also called Hallervorden-Spatz syndrome) and it is a major non-amyloid component of the deposits associated with Alzheimer's disease. Synuclein-beta may be a regulator of the SNCA aggregation process. It protects neurons from staurosporine and 6 hydroxy dopamine (6OHDA)-stimulated caspase activation that also involves p53 and contributes to restore the SNCA anti-apoptotic function abolished by 6OHDA. Gamma synuclein is found primarily in the peripheral nervous system and retina. High levels of expression have been identified in advanced breast carcinomas suggesting a correlation between overexpression of SNCG and breast tumor development.
  • Cellular localizationNeuronal cytosol and presynaptic terminals
  • Database links
  • Alternative names
    • BCSG1 antibody
    • beta synuclein antibody
    • Breast cancer specific gene 1 protein antibody
    • Gamma synuclein antibody
    • NACP antibody
    • PARK1 antibody
    • Persyn antibody
    • PRSN antibody
    • SNCA antibody
    • SNCB antibody
    • SNCG antibody
    • SR antibody
    • Synoretin antibody
    see all

Anti-pan Synuclein antibody, prediluted images

  • ab15535 staining pan Synuclein in Human brain tissue by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections).
  • ab15535 staining pan Synuclein in Human brain tissue.

References for Anti-pan Synuclein antibody, prediluted (ab15535)

ab15535 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab15535.
Please use the links above to contact us or submit feedback about this product.